Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183001 · ClinicalTrials.gov registry record · Phase 3
Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification
A Phase 3 study of Inflammation and Osteoporosis, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 3
- Development phase
- 452
- Enrollment target
- 1
- Study location
NCT00183001 is a Phase 3 study of Inflammation and Osteoporosis that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 452 participants, above the 285-participant average among 132 other Inflammation trials with a reported enrollment target (59% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00183001, a Phase 3 study of Inflammation and Osteoporosis, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 452 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if supplemental vitamin K will reduce age-related bone loss in elderly men and women above that achieved by supplementation.
Conditions Studied
Interventions
- DRUG Vitamin K
Study Locations (1)
Massachusetts
- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2001-10 |
| Est. Completion | 2006-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183001
The ClinicalTrials.gov registry entry for NCT00183001 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 452 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 285-participant average among 132 other Inflammation trials with a reported enrollment target (59% higher). The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Vitamin K is the first listed.
NCT00183001 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00183001 about?
NCT00183001 is a clinical study titled "Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification". The purpose of this study is to determine if supplemental vitamin K will reduce age-related bone loss in elderly men and women above that achieved by supplementation.
What is the current status of trial NCT00183001?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 452 participants. The study started on 2001-10. Estimated completion is 2006-10.
What conditions does trial NCT00183001 study?
This clinical trial studies the following conditions: Inflammation, Osteoporosis, Vascular Calcification.
What interventions are being tested in trial NCT00183001?
The interventions under investigation include: Vitamin K (DRUG).
Who is sponsoring clinical trial NCT00183001?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00183001 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation
COMPLETED · Phase 3
-
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
COMPLETED · Phase 3
-
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
COMPLETED · Phase 3
-
Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.